SHAPE Summit Presentations
AHA 2012 - Los Angeles, CA
if your browser asks for a password, please click cancel and the PowerPoint presentation will open
|
|
|
|
Daniel Berman, M.D. Director of Cardiac Imaging and of Nuclear Cardiology Opening Remarks
|
|
|
Morteza Naghavi, M.D. Founder of SHAPE and Executive Chairman of the SHAPE Task Force Moment of Silence Honoring the Late Dr. S Ward Casscells, a Pioneer in Early Detection of the "Vulnerable Patient"
|
|
|
Matthew Budoff, M.D. Director of Cardiac CT Imaging, Los Angeles Biomedical Research Institute: Professor of Medicine, Harbor UCLA Medical Center, Torrance, CA Latest developments in non-invasive imaging of atherosclerosis using coronary calcium
|
|
|
Tasneem Naqvi, M.D. Director, Echocardiography Services, Medical Director, Non Invasive Diagnostic Services, University of Southern California, Cardiac amd Vascular Institute, Los Angeles, CA Latest developments in non-invasive imaging of atherosclerosis using carotid ultrasound (CIMT and Plaque) In the New Era of PCI
|
|
|
Jagat Narula, M.D. Professor of Medicine, Philip J. and Harriet L. Goodhart Chair in Cardiology, Director of Cardiovascular Imaging Program, Mount Sinai's Zena and Michael A. Wiener Cardiovascular Health; Associate Dean for Global Health, Mount Sinai School of Medicine, New York, NY Coronary CT Angiography
|
|
|
P.K. Shah, M.D. Director, Division of Cardiology
|
|
|
Erling Falk, M.D., Ph.D. Chief of SHAPE Guidelines Editorial Committee Professor of Pathology and Cardiology, Aarhus University Hospital (Skejby), Aarhus, Denmark HRP BioImage Study: Preliminary Observations |
Presentation under embargo until HRP Trial |
|
Alan Rozanski, M.D. Interim Chief, Division of Cardiology, St. Luke's-Roosevelt Hospital Professor of Medicine, Columbia University College of Physicians and Surgeons Lessons Learned from the EISNER Trial
|
|
|
Harvey Hecht, M.D. Professor of Medicine, Associate Director of Cardiac Imaging, The Mount Sinai Medical Center, New York, NY Planned NIH Study: Comparing SHAPE with Status Quo
|
|
|
Raimund Erbel, M.D. Professor of Medicine, University of Essen Lessons learned from the Heinz Nixdorf Recall Study
|
|
|
Robert Superko, M.D. Chief of Medical Affairs – Celera What is the Role of Genetics and Biomarkers in Prevention?
|
|
|
|
|